U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C32H64O2
Molecular Weight 480.8494
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Cetyl palmitate

SMILES

CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC

InChI

InChIKey=PXDJXZJSCPSGGI-UHFFFAOYSA-N
InChI=1S/C32H64O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-34-32(33)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-31H2,1-2H3

HIDE SMILES / InChI
Molecular Formula C32H64O2
Molecular Weight 480.8494
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Cetyl Palmitate, wax-like substance, is used as an inactive ingredient in different cosmetic and personal care products e.g., in FINEVIN. This cream is used for the treatment of mild to moderate acne vulgaris. Cetyl Palmitate also functions as a binder to provide adhesive qualities during and after compression to make tablets or cakes.

Approval Year

1970
63
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
Approved
8429
FINEVIN

Approved Use

FINEVIN, a twice-daily topical azelaic acid cream, has been approved for the treatment of mild to moderate acne vulgaris.
PubMed

PubMed

TitleDatePubMed
Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits.
2001 Sep
Oral insulin delivery by means of solid lipid nanoparticles.
2007
Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.
2007
Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
2007 Apr 20
Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
2007 Aug
[Immobilization of lipase by chemical modification of chitosan].
2007 Jul
In vitro skin permeation of sunscreen agents from O/W emulsions.
2008 Feb
The effect of cetyl palmitate crystallinity on physical properties of gamma-oryzanol encapsulated in solid lipid nanoparticles.
2008 Mar 5
Solid lipid nanoparticles: a modern formulation approach in drug delivery system.
2009 Jul
Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
2009 Sep 10
Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations.
2010
Progress in antiretroviral drug delivery using nanotechnology.
2010 Aug 9
Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
2010 May
Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
2010 Oct 8
Patents

Patents

JPH09301842A
1
Substance Class Chemical
Created
by admin
on Fri Dec 15 14:58:57 GMT 2023
Edited
by admin
on Fri Dec 15 14:58:57 GMT 2023
Record UNII
5ZA2S6B08X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Cetyl palmitate
EP   II   INCI   MART.   MI   USP-RS   VANDF   WHO-DD  
INCI  
Official Name English
CETYL PALMITATE [USP-RS]
Common Name English
CETYL PALMITATE [MI]
Common Name English
CETYL PALMITATE [MART.]
Common Name English
Cetyl palmitate [WHO-DD]
Common Name English
CETYL PALMITATE [II]
Common Name English
CETYL PALMITATE [INCI]
Common Name English
CETYL PALMITATE [EP MONOGRAPH]
Common Name English
CETYL PALMITATE [VANDF]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C492
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL2106073
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
CHEBI
75584
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
FDA UNII
5ZA2S6B08X
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
MESH
C006957
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
PUBCHEM
10889
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
EPA CompTox
DTXSID5047114
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
NCI_THESAURUS
C77590
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
CAS
540-10-3
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
ECHA (EC/EINECS)
208-736-6
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
EVMPD
SUB13304MIG
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
MERCK INDEX
m3300
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY Merck Index
DAILYMED
5ZA2S6B08X
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
RXCUI
1311485
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY RxNorm
WIKIPEDIA
CETYL PALMITATE
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
RS_ITEM_NUM
1103105
Created by admin on Fri Dec 15 14:58:57 GMT 2023 , Edited by admin on Fri Dec 15 14:58:57 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966